ADC Therapeutics SA
NYSE:ADCT
ADC Therapeutics SA
Gross Profit
ADC Therapeutics SA
Gross Profit Peer Comparison
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
ADC Therapeutics SA
NYSE:ADCT
|
Gross Profit
$67m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
AC Immune SA
NASDAQ:ACIU
|
Gross Profit
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
Gross Profit
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Basilea Pharmaceutica AG
SIX:BSLN
|
Gross Profit
CHf130.8m
|
CAGR 3-Years
8%
|
CAGR 5-Years
3%
|
CAGR 10-Years
12%
|
|
Idorsia Ltd
SIX:IDIA
|
Gross Profit
CHf90.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Kuros Biosciences AG
SIX:KURN
|
Gross Profit
CHf28.5m
|
CAGR 3-Years
157%
|
CAGR 5-Years
115%
|
CAGR 10-Years
N/A
|
See Also
What is ADC Therapeutics SA's Gross Profit?
Gross Profit
67m
USD
Based on the financial report for Dec 31, 2023, ADC Therapeutics SA's Gross Profit amounts to 67m USD.
What is ADC Therapeutics SA's Gross Profit growth rate?
Gross Profit CAGR 1Y
-68%
Over the last year, the Gross Profit growth was -68%.